Microbot Medical EV/EBIT MBOT
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2019.
- Today, Oct 23, 2026
- n/m
- an operating loss
- Last meaningful
- 5.9×
- May 2020
- Peer median
- 13.3×
Microbot Medical has no meaningful EV/EBIT today: it made an operating loss of $18.5M over the last twelve months.
It was last meaningful in May 2020, at 5.9×.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2020 | 5.9× | 2.2× | 8.3× |
| 2019 | 5.8× | 1.9× | 5.8× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Microbot Medical's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| MBOTMicrobot Medical | n/m |
| APTAlpha Pro Tech | 8.2× |
| KEQUKewaunee Scientific | 7.2× |
| NEPHNephros | 20.5× |
| PDEXPro DEX | 16.0× |
| UTMDUtah Medical Products | 6.0× |
| INFUInfuSystem | 22.4× |
| EMBCEmbecta | 6.7× |
| TCMDTactile Systems Technology | 13.3× |
| MDXGMimedx | 51.6× |
| Peer median | 13.3× |
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Microbot Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.